김동욱 (을지대학교, 의정부을지대학교병원)님 | 한빛사연구자 > 한빛사

을지대학교, 의정부을지대학교병원

CV File

최종업데이트 2024.08.01.

KF1601, a dual inhibitor of BCR::ABL1 and FLT3, overcomes drug resistance in FLT3+ blast phase chronic myeloid leukemia
- Mol. Cancer, 14 April 2025 | https://doi.org/10.1186/s12943-025-02292-z
- 2025-04
- 한빛사논문
REXO5 promotes genomic integrity through regulating R-loop using its exonuclease activity
- Leukemia, Published: 30 July 2024 | https://doi.org/10.1038/s41375-024-02362-z
- 2024-07
- 바이오·의료융합
- 한빛사논문
Brain-Decellularized ECM-Based 3D Myeloid Sarcoma Platform: Mimicking Adaptive Phenotypic Alterations in the Brain
- Adv. Healthc. Mater., Feb 06 2024, | https://doi.org/10.1002/adhm.202304371
- 2024-02
- 바이오·의료융합
- 한빛사논문
Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia
- Mol. Cancer, 06 November 2023;22;177(2023) | https://doi.org/10.1186/s12943-023-01837-4
- 2023-11
- 생명과학
- 한빛사논문
- 김동욱(가톨릭대학교 의과대학, 서울성모병원)
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
- N. Engl. J. Med., December 12, 2019; 381:2315-2326 | DOI: 10.1056/NEJMoa1902328
- 2019-12
- 한빛사논문
GCA links TRAF6-ULK1-dependent autophagy activation in resistant chronic myeloid leukemia
- Autophagy, Published online: 30 Mar 2019 | https://doi.org/10.1080/15548627.2019.1596492
- 2019-03
- 생명과학
- 한빛사논문
Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia
- Leukemia, (2017) 31, 1532-1539 | doi: 10.1038/leu.2017.72
- 2017-02
- 생명과학
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기